Cernos Gel

Cernos Gel is a clinically approved topical testosterone replacement therapy (TRT) designed for the treatment of male hypogonadism, a condition characterized by low serum testosterone levels. Manufactured by Sun Pharmaceutical Industries Ltd., Cernos Gel offers a convenient, non-invasive transdermal delivery system that ensures steady testosterone absorption and physiological hormone restoration.

Each 5g sachet of Cernos Gel contains Testosterone 1% w/w (50 mg), formulated for once-daily application to clean, dry skin. It is indicated for adult men with primary or secondary hypogonadism due to pituitary or testicular disorders, helping to restore libido, energy levels, mood stability, muscle mass, and bone density.

Product Features:

• Active Ingredient: Testosterone (1% w/w, 50 mg per sachet)

• Form: Topical gel in single-use sachets

• Packaging: 14 or 30 sachets per box

• Administration: Transdermal application to shoulders, arms, or abdomen

Key Benefits:

• Maintains stable serum testosterone levels over 24 hours

• Non-invasive alternative to injections or oral tablets

• Minimizes hepatic metabolism and avoids first-pass effect

• Well-tolerated with a favorable safety profile in long-term use

Applications:

• Treatment of testosterone deficiency syndromes (hypogonadotropic or hypergonadotropic)

• Supportive therapy in male reproductive health programs

• Hormonal management in endocrinology clinics and men’s health centers

Quality & Compliance:

• Manufactured in WHO-GMP and USFDA-approved facilities

• Supplied with full documentation: CoA, MSDS, and pharmacokinetic data

• Regulatory labeling available for domestic and international markets